Max Healthcare to acquire YPPL for ₹200 Cr, plans ₹1,020 Cr hospital in Pune
Max Healthcare will acquire 100% equity in Yerawada Properties Private Limited (YPPL) for ~₹200 Crore. The company plans to set up a ~450-bedded hospital in Pune with an aggregate spend of up to ₹1,020 Crore. The acquisition and hospital development are expected to conclude over ~4 years.
The acquisition of a new entity and the significant investment in a new hospital represent a major strategic move that will substantially impact the company's future operations and market presence.
The announcement details a significant expansion plan through acquisition and new hospital development, indicating positive growth for the company.
Max Healthcare Institute Limited announced today, December 18, 2025, that its board of directors has approved the acquisition of 100% equity stake in Yerawada Properties Private Limited (YPPL), located in Pune, Maharashtra. The acquisition will be conducted in tranches, concluding upon receipt of the Occupancy Certificate for the planned hospital building.
The company will initially acquire 100% of Class A equity shares, representing full voting rights and approximately 50.22% of the economic interest in YPPL. The total aggregate spend for this acquisition and the development of a new ~450-bedded super specialty hospital on YPPL's land is capped at ₹1,020 Crore. This includes the cost of YPPL shares, construction, equipment, stamp duty, and registration charges.
The acquisition of YPPL, which owns a 1.68-acre parcel of freehold land in Yerawada, Pune, is expected to take approximately 4 years to complete. YPPL was incorporated as an LLP on February 19, 2024, and converted into a company on November 14, 2025. The company's paid-up capital and share premium stand at approximately ₹64.40 Crores, with a turnover not available (NA).
The new hospital in Pune aims to expand Max Healthcare's footprint in Maharashtra, a region experiencing growing demand for quality healthcare. The Max Healthcare network currently has approximately 5,200 beds as of September 30, 2025, with a capacity utilization of over 76% in H-1 FY26. The investment will be financed through a mix of internal accruals and term loans.
What to do with a filing like this
Max Healthcare Institute Limited filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Max Healthcare Institute Limited. Read the original for the full detail.